Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Non-liganded Vitamin D Receptor is crucial for healthy skin and hair.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

No treatment fully prevents hair loss from chemotherapy yet.

M30 is a promising treatment for preventing hair loss during chemotherapy.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Parathyroid hormone-related protein helps control hair growth phases in mice.

VDR regulation varies by tissue and is crucial for its biological functions.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.